CN106908609B - 肿瘤特异性移植抗原蛋白tsta3在制备食管鳞癌诊断试剂中的用途 - Google Patents
肿瘤特异性移植抗原蛋白tsta3在制备食管鳞癌诊断试剂中的用途 Download PDFInfo
- Publication number
- CN106908609B CN106908609B CN201710316413.4A CN201710316413A CN106908609B CN 106908609 B CN106908609 B CN 106908609B CN 201710316413 A CN201710316413 A CN 201710316413A CN 106908609 B CN106908609 B CN 106908609B
- Authority
- CN
- China
- Prior art keywords
- tsta3
- diagnosis
- squamous cell
- patients
- cell carcinoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/50—Determining the risk of developing a disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Pathology (AREA)
- Medicinal Chemistry (AREA)
- General Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (2)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710316413.4A CN106908609B (zh) | 2017-05-08 | 2017-05-08 | 肿瘤特异性移植抗原蛋白tsta3在制备食管鳞癌诊断试剂中的用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710316413.4A CN106908609B (zh) | 2017-05-08 | 2017-05-08 | 肿瘤特异性移植抗原蛋白tsta3在制备食管鳞癌诊断试剂中的用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106908609A CN106908609A (zh) | 2017-06-30 |
CN106908609B true CN106908609B (zh) | 2018-07-13 |
Family
ID=59209962
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710316413.4A Active CN106908609B (zh) | 2017-05-08 | 2017-05-08 | 肿瘤特异性移植抗原蛋白tsta3在制备食管鳞癌诊断试剂中的用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106908609B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN110716044B (zh) * | 2019-10-23 | 2023-04-18 | 郑州大学 | 一种用于食管鳞癌早期筛查和诊断的血清蛋白标志物、试剂盒及检测方法 |
CN111208304B (zh) * | 2020-01-20 | 2023-06-16 | 中国医学科学院北京协和医院 | 肿瘤来源IgG在甲状旁腺癌诊断和预后中的用途 |
CN111948394B (zh) * | 2020-08-10 | 2023-07-28 | 山西医科大学 | Tsta3与lamp2作为靶标物在食管鳞癌细胞转移检测、药物筛选中的应用 |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001018014A1 (en) * | 1999-09-03 | 2001-03-15 | Human Genome Sciences, Inc. | 29 human cancer associated proteins |
CN103025890A (zh) * | 2010-04-06 | 2013-04-03 | 卡里斯生命科学卢森堡控股 | 疾病的循环生物标志物 |
CN103492590A (zh) * | 2011-02-22 | 2014-01-01 | 卡里斯生命科学卢森堡控股有限责任公司 | 循环生物标志物 |
CN105279393A (zh) * | 2015-10-12 | 2016-01-27 | 厦门大学 | 一种基于权重网络评估药物不良反应的方法 |
WO2015195949A3 (en) * | 2014-06-18 | 2016-02-18 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
-
2017
- 2017-05-08 CN CN201710316413.4A patent/CN106908609B/zh active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001018014A1 (en) * | 1999-09-03 | 2001-03-15 | Human Genome Sciences, Inc. | 29 human cancer associated proteins |
CN103025890A (zh) * | 2010-04-06 | 2013-04-03 | 卡里斯生命科学卢森堡控股 | 疾病的循环生物标志物 |
CN103492590A (zh) * | 2011-02-22 | 2014-01-01 | 卡里斯生命科学卢森堡控股有限责任公司 | 循环生物标志物 |
WO2015195949A3 (en) * | 2014-06-18 | 2016-02-18 | Clear Gene, Inc. | Methods, compositions, and devices for rapid analysis of biological markers |
CN105279393A (zh) * | 2015-10-12 | 2016-01-27 | 厦门大学 | 一种基于权重网络评估药物不良反应的方法 |
Non-Patent Citations (2)
Title |
---|
High TSTA3 expression as a candidate biomarker of poor prognosis of ESCC patients;Zianyi Wang;《J Stem Cell Res Ther》;20170928;第7卷(第9期);65 * |
食管癌相关基因新作用伙伴p53的鉴定;崔永萍等;《山西医药杂志》;20080831;第37卷(第8期);700-701 * |
Also Published As
Publication number | Publication date |
---|---|
CN106908609A (zh) | 2017-06-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Bronsert et al. | Prognostic significance of Zinc finger E-box binding homeobox 1 (ZEB1) expression in cancer cells and cancer-associated fibroblasts in pancreatic head cancer | |
Karam et al. | Survivin expression in patients with non-muscle-invasive urothelial cell carcinoma of the bladder | |
Yang et al. | Tenascin-C, a prognostic determinant of esophageal squamous cell carcinoma | |
Park et al. | Focal adhesion kinase (FAK) gene amplification and its clinical implications in gastric cancer | |
Chen et al. | Significance of TLR4/MyD88 expression in breast cancer | |
Witkiewicz et al. | Association of RB/p16-pathway perturbations with DCIS recurrence: dependence on tumor versus tissue microenvironment | |
Tshering et al. | Biomarkers for the diagnosis of cholangiocarcinoma: a systematic review | |
Wang et al. | Overexpression of S100A2 protein as a prognostic marker for patients with stage I non small cell lung cancer | |
Faratian et al. | Membranous and cytoplasmic staining of Ki67 is associated with HER2 and ER status in invasive breast carcinoma | |
Rodrigo et al. | Immunohistochemical markers of distant metastasis in laryngeal and hypopharyngeal squamous cell carcinomas | |
CN106908609B (zh) | 肿瘤特异性移植抗原蛋白tsta3在制备食管鳞癌诊断试剂中的用途 | |
Gong et al. | Overexpression of Cripto and its prognostic significance in breast cancer: a study with long-term survival | |
Mizoshita et al. | Expression of the intestine-specific transcription factors, Cdx1 and Cdx2, correlates shift to an intestinal phenotype in gastric cancer cells | |
Taeb et al. | Expression of prostate stem cell antigen (PSCA) in prostate cancer: a tissue microarray study of Iranian patients | |
CN107085108A (zh) | 诊断癌症和确定癌症患者的总体生存和无病生存的方法 | |
CN105861692A (zh) | 研究***癌复发和转移的方法 | |
Bartuli et al. | Podoplanin in the development and progression of oral cavity cancer: a preliminary study | |
Chen et al. | Characterizing the activation of the Wnt signaling pathway in hilar cholangiocarcinoma using a tissue microarray approach | |
Adnan et al. | High CD44 Immunoexpression Correlates with Poor Overall Survival: Assessing the Role of Cancer Stem Cell Markers in Oral Squamous Cell Carcinoma Patients from the High‐Risk Population of Pakistan | |
CN104711341B (zh) | Dlk1基因在制备胃肠道间质瘤诊断试剂中的应用 | |
CN104422777A (zh) | Ano1蛋白在食管癌预后及癌前病变风险预测中的应用 | |
Dalbagni et al. | Prospective evaluation of p53 as a prognostic marker in T1 transitional cell carcinoma of the bladder | |
Pandey et al. | Loss of S100A14 expression at the tumor‐invading front correlates with poor differentiation and worse prognosis in oral squamous cell carcinoma | |
Acikalin et al. | Prognostic significance of galectin-3 and cyclin D1 expression in undifferentiated nasopharyngeal carcinoma | |
Hattori et al. | Clinicopathological significance of SPC 18 in colorectal cancer: SPC 18 participates in tumor progression |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
EE01 | Entry into force of recordation of patent licensing contract |
Application publication date: 20170630 Assignee: Shanxi Medical University Asset Management Co., Ltd Assignor: Shanxi Medial University Contract record no.: X2019980000611 Denomination of invention: Application of tumor-specific transplantation antigen protein TSTA3 in preparation of esophageal squamous carcinoma diagnosis reagent Granted publication date: 20180713 License type: Common License Record date: 20191115 |
|
EE01 | Entry into force of recordation of patent licensing contract | ||
EC01 | Cancellation of recordation of patent licensing contract |
Assignee: Shanxi Medical University Asset Management Co.,Ltd. Assignor: SHANXI MEDICAL University Contract record no.: X2019980000611 Date of cancellation: 20210422 |
|
EC01 | Cancellation of recordation of patent licensing contract |